Controversies Regarding Subclinical Leaflet Thrombosis After TAVR
Published: 25 February 2021
-
Views:
1184
-
Likes:
7
-
Views:
1184
-
Likes:
7
-
Up Next -
13m 38sPart 2 | Session 3 Panel discussion & Audience Questions
-
11m 47sPart 3 | Session 1 PRO -
15m 43sPart 3 | Session 2 CONTRA -
11m 57sPart 3 | Session 3 Panel discussion & Audience Questions
-
15m 20sPart 1 Subclinical leaflet thrombosis after TAVR: Numbers and facts Jolanta Siller-Matula
-
10m 22sPart 2 | Session 1 PRO Mamas A Mamas
Overview
A substantial number of patients develop a subclinical leaflet thrombosis (SLT) after transcatheter aortic valve replacement (TAVR).
The thrombus forms on the leaflets, which can lead to valve dysfunction and possibly to early valve degeneration. Multidetector computed tomography is the most sensitive imaging technique at detecting SLT.
Patients on antiplatelet drugs are at higher risk to develop SLT as compared to those on anticoagulants. During the live debate, the experts in the field will discuss controversies concerning SLT, including the routine use of oral anticoagulants and CT exams after TAVR.
Learning Objectives
- To learn about the natural history, incidence and clinical implications of SLT
- To learn about the mechanisms that may lead to SLT
- To understand the diagnostic criteria SLT
- To discuss the prevention and treatment options for SLT
Audience
- Interventional cardiologists with focus on TAVR procedures
- Cardiac Imaging specialists (Echocardiography, Computer Tomography)
- General cardiologists
- Specialists interested in management of antithrombotic therapies after TAVR
More from this programme
Part 1
Subclinical leaflet thrombosis after TAVR: Numbers and facts
Part 2
Debate: Patients should receive routine CT screening after TAVR to exclude subclinical valve thrombosis
Faculty Biographies
Poonam Velagapudi
Structural Interventional Cardiologist, Assistant Professor of Medicine and Associate Program Director for Cardiovascular Medicine fellowship at the University of Nebraska
Dr Poonam Velagapudi is a Structural Interventional Cardiologist, Assistant Professor of Medicine and Associate Program Director for Cardiovascular Medicine fellowship at the University of Nebraska. Her clinical interests include high risk PCI, mechanical circulatory support in shock, radial and large bore access, percutaneous transcatheter valve procedures including TAVR, TMVR, and MitraClip. She is a Fellow of the American College of Cardiology (ACC) and the Society for Cardiovascular Angiography and Interventions (SCAI), Chair of the ACC Early Career Section of the, Past Chair of the ACC Fellows in Training Section, and Co-Chair of the SCAI Educational Committee. Her focus is education, advocacy and increasing/promoting participation of women in clinical trials. She is a strong proponent of using social media for fostering education in cardiology and serves as the social media editor for JACC Interventions journal and Early Career Correspondent for ACC ACCEL Audio. She is an…